Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase

Alfredo Papa, Valerio Papa, Antonio Gasbarrini, Loris Riccardo Lopetuso, Antonio Tursi

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has raised several concerns for patients with chronic immune-mediated diseases, including inflammatory bowel disease (IBD). As the outbreak appears to be in the descending phase, at least in some part of the world, as in most European countries, guidance is urgently needed to provide optimal care for our IBD patients in order to gradually and safely reduce the gap in care that has been accumulated in the months of lockdown and to face all the backlogs. Therefore, we have provided a decalogue of practical recommendations for gastroenterologists to manage patients with IBD in the post-peak phase of the COVID-19 pandemic. They include all the aspects of IBD care, not only pharmacological ones but also endoscopy, surgery, psychological treatment, telemedicine, diagnostics and educational tasks provided by doctors and patient associations.
Original languageEnglish
Pages (from-to)1756284820968747-N/A
JournalTherapeutic Advances in Gastroenterology
Volume13
DOIs
Publication statusPublished - 2020

Keywords

  • COVID-19
  • endoscopy
  • inflammatory bowel disease
  • medical treatment
  • surgery

Fingerprint

Dive into the research topics of 'Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase'. Together they form a unique fingerprint.

Cite this